awacke1/LOINC-Clinical-Terminology · Datasets at Hugging Face

LOINC_NUM stringlengths 3 8	COMPONENT stringlengths 2 246	PROPERTY stringlengths 1 29	TIME_ASPCT stringlengths 1 15	SYSTEM stringlengths 1 106	SCALE_TYP stringclasses 10 values	METHOD_TYP stringlengths 1 57 ⌀	CLASS stringlengths 2 24	CLASSTYPE int64 1 4	LONG_COMMON_NAME stringlengths 3 254	SHORTNAME stringlengths 2 51 ⌀	EXTERNAL_COPYRIGHT_NOTICE stringlengths 39 2.6k ⌀	STATUS stringclasses 4 values	VersionFirstReleased stringlengths 1 7	VersionLastChanged stringlengths 1 5
95724-1	Glycine receptor Ab	PrThr	Pt	Ser/Plas	Ord	IF	SERO	1	Glycine receptor Ab [Presence] in Serum or Plasma by Immunofluorescence	GlyR Ab SerPl Ql IF	null	ACTIVE	2.69	2.69
95725-8	Glycine receptor Ab	PrThr	Pt	CSF	Ord	IF	SERO	1	Glycine receptor Ab [Presence] in Cerebral spinal fluid by Immunofluorescence	GlyR Ab CSF Ql IF	null	ACTIVE	2.69	2.69
95726-6	3-Hydroxy-3-Methylglutaryl-Coenzyme A reductase Ab	ACnc	Pt	Ser/Plas	Qn	IA	SERO	1	3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab [Units/volume] in Serum or Plasma by Immunoassay	HMGCR Ab SerPl IA-aCnc	null	ACTIVE	2.69	2.69
95727-4	Name	Pn	Pt	^Contact	Nom	null	ADMIN	2	Contact Name	Contact Name	null	ACTIVE	2.69	2.69
95728-2	Address	Addr	Pt	^Contact	Nom	null	ADMIN	2	Contact Address	Contact Address	null	ACTIVE	2.69	2.69
9572-9	Parvovirus B19 DNA	PrThr	Pt	Ser	Ord	Probe.amp.tar	MICRO	1	Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection	B19V DNA Ser Ql NAA+probe	null	ACTIVE	1.0i	2.73
95729-0	Relationship to decedent	Type	Pt	^Contact	Nom	null	ADMIN	2	Relationship to decedent Contact	Rel to decedent Contact	null	ACTIVE	2.69	2.69
95730-8	Surviving spouse name	Pn	Pt	^Patient	Nom	null	ADMIN	2	Surviving spouse name	Surviving spouse name	null	ACTIVE	2.69	2.69
95731-6	Maiden name	Pn	Pt	^Mother	Nom	null	ADMIN	2	Mother's Maiden name	Mother's Maiden name	null	ACTIVE	2.69	2.69
95732-4	IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Self-care - admission performance	-	RptPeriod	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Self-care - admission performance during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.7
95733-2	IRF-PAI v3.0, LCDS v4.00 - Bladder and bowel - admission	-	RptPeriod	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	IRF-PAI v3.0, LCDS v4.00 - Bladder and bowel - admission during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.69
95734-0	IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Self-care - discharge performance	-	RptPeriod	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	IRF-PAIv3.0, MDS v1.17.1, 1.17.2 - Self-care - discharge performance during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.7
95735-7	Bladder continence	Find	RptPeriod	^Patient	Ord	CMS Assessment	SURVEY.CMS	4	Bladder continence during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.69
95736-5	Bowel continence	Find	RptPeriod	^Patient	Ord	CMS Assessment	SURVEY.CMS	4	Bowel continence during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.69
9573-7	Respiratory syncytial virus Ab.IgG	Titr	Pt	Ser	Qn	IF	MICRO	1	Respiratory syncytial virus IgG Ab [Titer] in Serum by Immunofluorescence	RSV IgG Titr Ser IF	null	ACTIVE	1.0i	2.73
95737-3	Expression of ideas and wants	Find	RptPeriod	^Patient	Ord	CMS Assessment	SURVEY.CMS	4	Expression of ideas and wants during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.69
95738-1	Does the patient use a wheelchair or scooter	Find	RptPeriod	^Patient	Ord	CMS Assessment	SURVEY.CMS	4	Does the patient use a wheelchair/scooter during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.69
95739-9	Indicate the type of wheelchair or scooter used	Type	RptPeriod	^Patient	Nom	CMS Assessment	SURVEY.CMS	4	Indicate the type of wheelchair/scooter used during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.69
95740-7	Understanding verbal and non-verbal content	Find	RptPeriod	^Patient	Ord	CMS Assessment	SURVEY.CMS	4	Understanding verbal and non-verbal content during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.69
95741-5	IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Mobility - admission performance	-	RptPeriod	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Mobility - admission performance during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.7
95742-3	IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Mobility - discharge performance	-	RptPeriod	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Mobility - discharge performance during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.7
95743-1	Memory &or recall ability	Find	RptPeriod	^Patient	Nom	CMS Assessment	SURVEY.CMS	4	Memory/recall ability during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.69
95744-9	Hearing.ability to hear	Find	RptPeriod	^Patient	Ord	CMS Assessment	SURVEY.CMS	4	Hearing.ability to hear during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.69
9574-5	Respiratory syncytial virus Ab.IgM	Titr	Pt	Ser	Qn	IF	MICRO	1	Respiratory syncytial virus IgM Ab [Titer] in Serum by Immunofluorescence	RSV IgM Titr Ser IF	null	ACTIVE	1.0i	2.73
95745-6	Vision.ability to see in adequate light	Find	RptPeriod	^Patient	Ord	CMS Assessment	SURVEY.CMS	4	Vision.ability to see in adequate light during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.69
95746-4	Progress note	Find	Pt	{Setting}	Doc	Immunology	DOC.ONTOLOGY	2	Immunology Progress note	Immunology Prog note	null	ACTIVE	2.69	2.73
95747-2	Referral note	Find	Pt	{Setting}	Doc	Immunology	DOC.ONTOLOGY	2	Immunology Referral note	Immunology Referral note	null	ACTIVE	2.69	2.69
95748-0	Education note	Find	Pt	{Setting}	Doc	Immunology	DOC.ONTOLOGY	2	Immunology Education note	Immunology Educ note	null	ACTIVE	2.69	2.69
95749-8	Initial evaluation note	Find	Pt	{Setting}	Doc	Immunology	DOC.ONTOLOGY	2	Immunology Initial evaluation note	Immunology Initial eval note	null	ACTIVE	2.69	2.69
95750-6	Procedure note	Find	Pt	{Setting}	Doc	Immunology	DOC.ONTOLOGY	2	Immunology procedure note	Immunology Procedure note	null	ACTIVE	2.69	2.69
95751-4	Flowsheet	Find	Pt	{Setting}	Doc	Immunology	DOC.ONTOLOGY	2	Immunology Flowsheet	Immunology Flowsheet	null	ACTIVE	2.69	2.69
9575-2	Rotavirus Ab	Titr	Pt	Ser	Qn	Comp fix	MICRO	1	Rotavirus Ab [Titer] in Serum by Complement fixation	RV Ab Titr Ser CF	null	DISCOURAGED	1.0i	2.7
95752-2	Plan of care note	Find	Pt	{Setting}	Doc	Immunology	DOC.ONTOLOGY	2	Immunology Plan of care note	Immunology Plan of care note	null	ACTIVE	2.69	2.69
95753-0	Evaluation note	Find	Pt	{Setting}	Doc	Immunology	DOC.ONTOLOGY	2	Immunology Evaluation note	Immunology Eval note	null	ACTIVE	2.69	2.69
95754-8	Referral note	Find	Pt	{Setting}	Doc	Allergy	DOC.ONTOLOGY	2	Allergy Referral note	Allergy Referral note	null	ACTIVE	2.69	2.69
95755-5	Initial evaluation note	Find	Pt	{Setting}	Doc	Allergy	DOC.ONTOLOGY	2	Allergy Initial evaluation note	Allergy Initial eval note	null	ACTIVE	2.69	2.69
95756-3	Procedure note	Find	Pt	{Setting}	Doc	Allergy	DOC.ONTOLOGY	2	Allergy procedure note	Allergy Procedure note	null	ACTIVE	2.69	2.69
95757-1	Progress note	Find	Pt	{Setting}	Doc	Allergy	DOC.ONTOLOGY	2	Allergy Progress note	Allergy Prog note	null	ACTIVE	2.69	2.73
95758-9	Flowsheet	Find	Pt	{Setting}	Doc	Allergy	DOC.ONTOLOGY	2	Allergy Flowsheet	Allergy Flowsheet	null	ACTIVE	2.69	2.69
95759-7	Plan of care note	Find	Pt	{Setting}	Doc	Allergy	DOC.ONTOLOGY	2	Allergy Plan of care note	Allergy Plan of care note	null	ACTIVE	2.69	2.69
9576-0	Rubella virus Ab	ACnc	Pt	CSF	Qn	IA	MICRO	1	Rubella virus Ab [Units/volume] in Cerebral spinal fluid by Immunoassay	RUBV Ab CSF IA-aCnc	null	ACTIVE	1.0i	2.69
95760-5	Education note	Find	Pt	{Setting}	Doc	Allergy	DOC.ONTOLOGY	2	Allergy Education note	Allergy Educ note	null	ACTIVE	2.69	2.69
95761-3	Consultation note	Find	Pt	{Setting}	Doc	Allergy	DOC.ONTOLOGY	2	Allergy Consult note	Allergy Consult note	null	ACTIVE	2.69	2.69
95762-1	Diagnostic study note	Find	Pt	{Setting}	Doc	Allergy	DOC.ONTOLOGY	2	Allergy Diagnostic study note	Allergy Diag study note	null	ACTIVE	2.69	2.69
95763-9	Evaluation note	Find	Pt	{Setting}	Doc	Allergy	DOC.ONTOLOGY	2	Allergy Evaluation note	Allergy Eval note	null	ACTIVE	2.69	2.69
95764-7	Candida auris DNA	PrThr	Pt	Urine	Ord	Non-probe.amp.tar	MICRO	1	Candida auris DNA [Presence] in Urine by NAA with non-probe detection	C auris DNA Ur Ql NAA+non-probe	null	ACTIVE	2.69	2.69
95765-4	Candida auris DNA	PrThr	Pt	XXX	Ord	Non-probe.amp.tar	MICRO	1	Candida auris DNA [Presence] in Specimen by NAA with non-probe detection	C auris DNA Spec Ql NAA+non-probe	null	ACTIVE	2.69	2.69
95766-2	Candida auris DNA	PrThr	Pt	Bld	Ord	Non-probe.amp.tar	MICRO	1	Candida auris DNA [Presence] in Blood by NAA with non-probe detection	C auris DNA Bld Ql NAA+non-probe	null	ACTIVE	2.69	2.69
95767-0	Cefiderocol	Susc	Pt	Isolate	OrdQn	Agar diffusion	ABXBACT	1	Cefiderocol [Susceptibility] by Disk diffusion (KB)	Cefiderocol Islt KB	null	ACTIVE	2.69	2.69
95768-8	Parathyrin.1-84	SCnc	Pt	Ser/Plas	Qn	IA	CHEM	1	Parathyrin.1-84 [Moles/volume] in Serum or Plasma by Immunoassay	Parathyrin.1-84 SerPl IA-sCnc	null	ACTIVE	2.69	2.71
95769-6	BMPR1A gene deletion+duplication & full mutation analysis	Find	Pt	Bld/Tiss	Doc	Molgen	MOLPATH	1	BMPR1A gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method	BMPR1A Del+Dup + Full Mut Anl Bld/T	null	ACTIVE	2.69	2.69
95770-4	GALT gene targeted mutation analysis	Find	Pt	Bld/Tiss	Doc	Molgen	MOLPATH	1	GALT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method	GALT gene Mut Anl Bld/T	null	ACTIVE	2.69	2.69
95771-2	GATA2 gene full mutation analysis	Find	Pt	Bld/Tiss	Doc	Sequencing	MOLPATH	1	GATA2 gene full mutation analysis in Blood or Tissue by Sequencing	GATA2 gene Full Mut Anl Bld/T Seq	null	ACTIVE	2.69	2.69
95772-0	IDH1 gene & IDH2 gene targeted mutation analysis	Find	Pt	Bld/Tiss	Doc	Molgen	MOLPATH	1	IDH1 and IDH2 genes targeted mutation analysis in Blood or Tissue by Molecular genetics method	IDH1 + IDH2 Mut Anl Bld/T	null	ACTIVE	2.69	2.69
95773-8	ACADM gene full mutation analysis	Find	Pt	Bld/Tiss	Doc	Sequencing	MOLPATH	1	ACADM gene full mutation analysis in Blood or Tissue by Sequencing	ACADM gene Full Mut Anl Bld/T Seq	null	ACTIVE	2.69	2.69
95774-6	MSH6 gene deletion+duplication & full mutation analysis	Find	Pt	Bld/Tiss	Doc	Molgen	MOLPATH	1	MSH6 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method	MSH6 gene Del+Dup + Full Mut Anl Bld/T	null	ACTIVE	2.69	2.69
95775-3	HGSNAT gene full mutation analysis	Find	Pt	Bld/Tiss	Doc	Sequencing	MOLPATH	1	HGSNAT gene full mutation analysis in Blood or Tissue by Sequencing	HGSNAT Full Mut Anl Bld/T Seq	null	ACTIVE	2.69	2.69
95776-1	GNS gene full mutation analysis	Find	Pt	Bld/Tiss	Doc	Sequencing	MOLPATH	1	GNS gene full mutation analysis in Blood or Tissue by Sequencing	GNS Full Mut Anl Bld/T Seq	null	ACTIVE	2.69	2.69
95777-9	ACADS gene full mutation analysis	Find	Pt	Bld/Tiss	Doc	Sequencing	MOLPATH	1	ACADS gene full mutation analysis in Blood or Tissue by Sequencing	ACADS gene Full Mut Anl Bld/T Seq	null	ACTIVE	2.69	2.69
9577-8	Saint Louis encephalitis virus Ab	Titr	Pt	CSF	Qn	IF	MICRO	1	Saint Louis encephalitis virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence	SLEV Ab Titr CSF IF	null	ACTIVE	1.0i	2.7
95778-7	TERT gene promotor region targeted mutation analysis	Find	Pt	Tiss	Doc	Molgen	MOLPATH	1	TERT gene promotor region targeted mutation analysis in Tissue by Molecular genetics method	TERT promotor region Mut Anl Tiss	null	ACTIVE	2.69	2.69
95779-5	TFE3 gene rearrangements	Find	Pt	Tiss	Doc	FISH	MOLPATH	1	TFE3 gene rearrangements in Tissue by FISH	TFE3 rearrange Tiss FISH	null	ACTIVE	2.69	2.69
95780-3	TFEB gene rearrangements	Find	Pt	Tiss	Doc	FISH	MOLPATH	1	TFEB gene rearrangements in Tissue by FISH	TFEB rearrange Tiss FISH	null	ACTIVE	2.69	2.69
95781-1	ATP7B gene full mutation analysis	Find	Pt	Bld/Tiss	Doc	Sequencing	MOLPATH	1	ATP7B gene full mutation analysis in Blood or Tissue by Sequencing	ATP7B gene Full Mut Anl Bld/T Seq	null	ACTIVE	2.69	2.69
95782-9	ABCD1 gene full mutation analysis	Find	Pt	Bld/Tiss	Doc	Sequencing	MOLPATH	1	ABCD1 gene full mutation analysis in Blood or Tissue by Sequencing	ABCD1 gene Full Mut Anl Bld/T Seq	null	ACTIVE	2.69	2.69
95783-7	ETV6 gene rearrangements	Find	Pt	Bld/Bone mar	Doc	FISH	MOLPATH	1	ETV6 gene rearrangements in Blood or Marrow by FISH	ETV6 rearrange Bld/Mar FISH	null	ACTIVE	2.69	2.69
95784-5	FGFR2 gene rearrangements	Find	Pt	Tiss	Doc	FISH	MOLPATH	1	FGFR2 gene rearrangements in Tissue by FISH	FGFR2 rearrange Tiss FISH	null	ACTIVE	2.69	2.69
95785-2	FOXL2 gene targeted mutation analysis	Find	Pt	Tiss	Doc	Molgen	MOLPATH	1	FOXL2 gene targeted mutation analysis in Tissue by Molecular genetics method	FOXL2 Mut Anl Tiss	null	ACTIVE	2.69	2.69
9578-6	Saint Louis encephalitis virus Ab	Titr	Pt	Ser	Qn	IF	MICRO	1	Saint Louis encephalitis virus Ab [Titer] in Serum by Immunofluorescence	SLEV Ab Titr Ser IF	null	ACTIVE	1.0i	2.73
95786-0	Gene XXX mutation analysis limited to known familial mutations	Find	Pt	Bld/Tiss	Doc	Molgen	MOLPATH	1	Gene XXX mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method	Gene XXX Fam Mut Anl Bld/T	null	ACTIVE	2.69	2.69
95787-8	Adrenal cortical carcinoma probability	Likelihood	Pt	^Patient	Qn	Based on clinical data	CLIN.RISK	2	Adrenal cortical carcinoma probability [Likelihood] based on clinical data	ACC Prob from clin data	null	ACTIVE	2.69	2.69
95788-6	Adrenal malignancy other than adrenal cortical carcinoma probability	Likelihood	Pt	^Patient	Qn	Based on clinical data	CLIN.RISK	2	Adrenal malignancy other than ACC probability [Likelihood] based on clinical data	Other adrenal malig Prob from clin data	null	ACTIVE	2.69	2.69
95789-4	Benign mass probability	Likelihood	Pt	^Patient	Qn	Based on clinical data	CLIN.RISK	2	Benign mass probability [Likelihood] based on clinical data	Benign mass Prob from clin data	null	ACTIVE	2.69	2.69
95790-2	Adrenal cortical carcinoma probability	Likelihood	Pt	^Patient	Qn	Based on clinical+lab data	CLIN.RISK	2	Adrenal cortical carcinoma probability [Likelihood] based on clinical and lab data	ACC Prob from clin+lab data	null	ACTIVE	2.69	2.69
95791-0	Adrenal malignancy other than adrenal cortical carcinoma probability	Likelihood	Pt	^Patient	Qn	Based on clinical+lab data	CLIN.RISK	2	Adrenal malignancy other than ACC probability [Likelihood] based on clinical and lab data	Other adrenal malig Prob clin+lab data	null	ACTIVE	2.69	2.69
95792-8	Benign mass probability	Likelihood	Pt	^Patient	Qn	Based on clinical+lab data	CLIN.RISK	2	Benign mass probability [Likelihood] based on clinical and lab data	Benign mass Prob from clin+lab data	null	ACTIVE	2.69	2.69
95793-6	Immunization priority tier	Type	Pt	^Patient	Nom	null	PUBLICHEALTH	2	Immunization priority tier	Immunization priority tier	null	ACTIVE	2.69	2.69
9579-4	Tetrahydrocorticosterone	MRat	24H	Urine	Qn	null	CHEM	1	Tetrahydrocorticosterone [Mass/time] in 24 hour Urine	THB 24h Ur-mRate	null	ACTIVE	1.0i	2.42
95794-4	Adrenal insufficiency emergency action plan	Find	Pt	{Setting}	Doc	{Role}	DOC.ONTOLOGY	2	Adrenal insufficiency emergency action plan	Adrenal insufficiency action plan	null	ACTIVE	2.69	2.69
95795-1	HBG1 gene & HBG2 gene full mutation analysis	Find	Pt	Bld/Tiss	Doc	Sequencing	MOLPATH	1	HBG1 and HBG2 genes full mutation analysis in Blood or Tissue by Sequencing	HBG1 + HBG2 Full Mut Anl Bld/T Seq	null	ACTIVE	2.69	2.73
95796-9	Opioids panel	-	Pt	Urine	-	Screen	PANEL.DRUG/TOX	1	Opioids panel - Urine by Screen method	Opioids Pnl Ur Scn	null	ACTIVE	2.69	2.69
95797-7	Norfentanyl	PrThr	Pt	Urine	Ord	Screen	DRUG/TOX	1	Norfentanyl [Presence] in Urine by Screen method	Norfentanyl Ur Ql Scn	null	ACTIVE	2.69	2.69
95798-5	Normeperidine	PrThr	Pt	Urine	Ord	Screen	DRUG/TOX	1	Normeperidine [Presence] in Urine by Screen method	Normeperidine Ur Ql Scn	null	ACTIVE	2.69	2.69
95799-3	O-nortramadol	PrThr	Pt	Urine	Ord	Screen	DRUG/TOX	1	O-nortramadol [Presence] in Urine by Screen method	O-nortramadol Ur Ql Scn	null	ACTIVE	2.69	2.69
95800-9	Immunoglobulin light chains.free panel	-	-	Urine	-	null	PANEL.CHEM	1	Immunoglobulin light chains.free panel - Urine	Immunoglobulin LC free Pnl Ur	null	ACTIVE	2.69	2.69
95801-7	Immunoglobulin light chains.free & immunofixation panel	-	-	Urine	-	null	PANEL.CHEM	1	Immunoglobulin light chains.free and IFE panel - Urine	Immunoglobulin LC free + IFE Pnl Ur	null	ACTIVE	2.69	2.69
9580-2	Thyroxine Ab	ACnc	Pt	Ser	Qn	null	SERO	1	Thyroxine (T4) Ab [Units/volume] in Serum	T4 Ab Ser-aCnc	null	ACTIVE	1.0i	2.73
95802-5	Progress note	Find	Pt	{Setting}	Doc	Breastfeeding	DOC.ONTOLOGY	2	Breastfeeding Progress note	Breastfeeding Prog note	null	ACTIVE	2.69	2.73
95803-3	Note	Find	Pt	{Setting}	Doc	Breastfeeding	DOC.ONTOLOGY	2	Breastfeeding Note	Breastfeeding Note	null	ACTIVE	2.69	2.69
95804-1	Note	Find	Pt	Telehealth	Doc	Breastfeeding	DOC.ONTOLOGY	2	Breastfeeding Telehealth Note	Breastfeeding Telehealth Note	null	ACTIVE	2.69	2.69
95805-8	Evaluation note	Find	Pt	{Setting}	Doc	Breastfeeding	DOC.ONTOLOGY	2	Breastfeeding Evaluation note	Breastfeeding Eval note	null	ACTIVE	2.69	2.69
95806-6	Consultation note	Find	Pt	{Setting}	Doc	Breastfeeding	DOC.ONTOLOGY	2	Breastfeeding Consult note	Breastfeeding Consult note	null	ACTIVE	2.69	2.69
95807-4	Chylomicrons	PrThr	Pt	Urine	Ord	null	CHEM	1	Chylomicrons [Presence] in Urine	Chylo Ur Ql	null	ACTIVE	2.69	2.69
95808-2	Cholesterol & triglyceride & chylomicrons panel	-	Pt	Urine	-	null	PANEL.CHEM	1	Cholesterol and triglyceride and chylomicrons panel - Urine	Cholest+triglyceride+chylomicrons Pnl Ur	null	ACTIVE	2.69	2.69
95809-0	Carbapenem resistance genes	PrThr	Pt	Isolate/Specimen	Ord	Molgen	ABXBACT	1	Carbapenem resistance genes [Presence] by Molecular method	CPR genes Islt/Spm Ql	null	ACTIVE	2.69	2.69
9581-0	Western equine encephalitis virus Ab	Titr	Pt	Ser	Qn	IF	MICRO	1	Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence	WEEV Ab Titr Ser IF	null	ACTIVE	1.0i	2.73
95810-8	IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Functional abilities and goals - discharge	-	RptPeriod	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Functional abilities and goals - discharge [CMS Assessment]	null	null	ACTIVE	2.69	2.7
95811-6	IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Functional abilities and goals - admission	-	-	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Functional abilities and goals - admission [CMS Assessment]	null	null	ACTIVE	2.69	2.7
95812-4	Did the patient have difficulty focusing attention, for example, being easily distractible or having difficulty keeping track of what was being said	Find	RptPeriod	^Patient	Ord	CAM.CMS	SURVEY.CMS	4	Did the patient have difficulty focusing attention, for example, being easily distractible or having difficulty keeping track of what was being said during assessment period [CAM.CMS]	null	Copyright © 2003 Sharon K. Inouye, M.D., MPH. Adapted from: Inouye SK, vanDyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: The Confusion Assessment Method. A new method for detection of delirium. Ann Intern Med. 1990; 113: 941-948. Confusion Assessment Method: Training Manual and Coding Guide. Used with permission.	ACTIVE	2.69	2.69
95813-2	Is there evidence of an acute change in mental status from the patient's baseline	Find	RptPeriod	^Patient	Ord	CAM.CMS	SURVEY.CMS	4	Is there evidence of an acute change in mental status from the patient's baseline during assessment period [CAM.CMS]	null	Copyright © 2003 Sharon K. Inouye, M.D., MPH. Adapted from: Inouye SK, vanDyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: The Confusion Assessment Method. A new method for detection of delirium. Ann Intern Med. 1990; 113: 941-948. Confusion Assessment Method: Training Manual and Coding Guide. Used with permission.	ACTIVE	2.69	2.69

95724-1

Glycine receptor Ab

PrThr

Pt

Ser/Plas

Ord

IF

SERO

1

Glycine receptor Ab [Presence] in Serum or Plasma by Immunofluorescence

GlyR Ab SerPl Ql IF

null

ACTIVE

2.69

95725-8

Glycine receptor Ab

PrThr

Pt

CSF

Ord

IF

SERO

1

Glycine receptor Ab [Presence] in Cerebral spinal fluid by Immunofluorescence

GlyR Ab CSF Ql IF

null

ACTIVE

2.69

95726-6

3-Hydroxy-3-Methylglutaryl-Coenzyme A reductase Ab

ACnc

Pt

Ser/Plas

Qn

IA

SERO

1

3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab [Units/volume] in Serum or Plasma by Immunoassay

HMGCR Ab SerPl IA-aCnc

null

ACTIVE

2.69

95727-4

Name

Pn

Pt

^Contact

Nom

null

ADMIN

2

Contact Name

null

ACTIVE

2.69

95728-2

Address

Addr

Pt

^Contact

Nom

null

ADMIN

2

Contact Address

null

ACTIVE

2.69

9572-9

Parvovirus B19 DNA

PrThr

Pt

Ser

Ord

Probe.amp.tar

MICRO

1

Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

B19V DNA Ser Ql NAA+probe

null

ACTIVE

1.0i

2.73

95729-0

Relationship to decedent

Type

Pt

^Contact

Nom

null

ADMIN

2

Relationship to decedent Contact

Rel to decedent Contact

null

ACTIVE

2.69

95730-8

Surviving spouse name

Pn

Pt

^Patient

Nom

null

ADMIN

2

Surviving spouse name

null

ACTIVE

2.69

95731-6

Maiden name

Pn

Pt

^Mother

Nom

null

ADMIN

2

Mother's Maiden name

null

ACTIVE

2.69

95732-4

IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Self-care - admission performance

-

RptPeriod

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Self-care - admission performance during assessment period [CMS Assessment]

null

ACTIVE

2.69

2.7

95733-2

IRF-PAI v3.0, LCDS v4.00 - Bladder and bowel - admission

-

RptPeriod

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

IRF-PAI v3.0, LCDS v4.00 - Bladder and bowel - admission during assessment period [CMS Assessment]

null

ACTIVE

2.69

95734-0

IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Self-care - discharge performance

-

RptPeriod

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

IRF-PAIv3.0, MDS v1.17.1, 1.17.2 - Self-care - discharge performance during assessment period [CMS Assessment]

null

ACTIVE

2.69

2.7

95735-7

Bladder continence

Find

RptPeriod

^Patient

Ord

CMS Assessment

SURVEY.CMS

4

Bladder continence during assessment period [CMS Assessment]

null

ACTIVE

2.69

95736-5

Bowel continence

Find

RptPeriod

^Patient

Ord

CMS Assessment

SURVEY.CMS

4

Bowel continence during assessment period [CMS Assessment]

null

ACTIVE

2.69

9573-7

Respiratory syncytial virus Ab.IgG

Titr

Pt

Ser

Qn

IF

MICRO

1

Respiratory syncytial virus IgG Ab [Titer] in Serum by Immunofluorescence

RSV IgG Titr Ser IF

null

ACTIVE

1.0i

2.73

95737-3

Expression of ideas and wants

Find

RptPeriod

^Patient

Ord

CMS Assessment

SURVEY.CMS

4

Expression of ideas and wants during assessment period [CMS Assessment]

null

ACTIVE

2.69

95738-1

Does the patient use a wheelchair or scooter

Find

RptPeriod

^Patient

Ord

CMS Assessment

SURVEY.CMS

4

Does the patient use a wheelchair/scooter during assessment period [CMS Assessment]

null

ACTIVE

2.69

95739-9

Indicate the type of wheelchair or scooter used

Type

RptPeriod

^Patient

Nom

CMS Assessment

SURVEY.CMS

4

Indicate the type of wheelchair/scooter used during assessment period [CMS Assessment]

null

ACTIVE

2.69

95740-7

Understanding verbal and non-verbal content

Find

RptPeriod

^Patient

Ord

CMS Assessment

SURVEY.CMS

4

Understanding verbal and non-verbal content during assessment period [CMS Assessment]

null

ACTIVE

2.69

95741-5

IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Mobility - admission performance

-

RptPeriod

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Mobility - admission performance during assessment period [CMS Assessment]

null

ACTIVE

2.69

2.7

95742-3

IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Mobility - discharge performance

-

RptPeriod

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Mobility - discharge performance during assessment period [CMS Assessment]

null

ACTIVE

2.69

2.7

95743-1

Memory &or recall ability

Find

RptPeriod

^Patient

Nom

CMS Assessment

SURVEY.CMS

4

Memory/recall ability during assessment period [CMS Assessment]

null

ACTIVE

2.69

95744-9

Hearing.ability to hear

Find

RptPeriod

^Patient

Ord

CMS Assessment

SURVEY.CMS

4

Hearing.ability to hear during assessment period [CMS Assessment]

null

ACTIVE

2.69

9574-5

Respiratory syncytial virus Ab.IgM

Titr

Pt

Ser

Qn

IF

MICRO

1

Respiratory syncytial virus IgM Ab [Titer] in Serum by Immunofluorescence

RSV IgM Titr Ser IF

null

ACTIVE

1.0i

2.73

95745-6

Vision.ability to see in adequate light

Find

RptPeriod

^Patient

Ord

CMS Assessment

SURVEY.CMS

4

Vision.ability to see in adequate light during assessment period [CMS Assessment]

null

ACTIVE

2.69

95746-4

Progress note

Find

Pt

{Setting}

Doc

Immunology

DOC.ONTOLOGY

2

Immunology Progress note

Immunology Prog note

null

ACTIVE

2.69

2.73

95747-2

Referral note

Find

Pt

{Setting}

Doc

Immunology

DOC.ONTOLOGY

2

Immunology Referral note

null

ACTIVE

2.69

95748-0

Education note

Find

Pt

{Setting}

Doc

Immunology

DOC.ONTOLOGY

2

Immunology Education note

Immunology Educ note

null

ACTIVE

2.69

95749-8

Initial evaluation note

Find

Pt

{Setting}

Doc

Immunology

DOC.ONTOLOGY

2

Immunology Initial evaluation note

Immunology Initial eval note

null

ACTIVE

2.69

95750-6

Procedure note

Find

Pt

{Setting}

Doc

Immunology

DOC.ONTOLOGY

2

Immunology procedure note

Immunology Procedure note

null

ACTIVE

2.69

95751-4

Flowsheet

Find

Pt

{Setting}

Doc

Immunology

DOC.ONTOLOGY

2

Immunology Flowsheet

null

ACTIVE

2.69

9575-2

Rotavirus Ab

Titr

Pt

Ser

Qn

Comp fix

MICRO

1

Rotavirus Ab [Titer] in Serum by Complement fixation

RV Ab Titr Ser CF

null

DISCOURAGED

1.0i

2.7

95752-2

Plan of care note

Find

Pt

{Setting}

Doc

Immunology

DOC.ONTOLOGY

2

Immunology Plan of care note

null

ACTIVE

2.69

95753-0

Evaluation note

Find

Pt

{Setting}

Doc

Immunology

DOC.ONTOLOGY

2

Immunology Evaluation note

Immunology Eval note

null

ACTIVE

2.69

95754-8

Referral note

Find

Pt

{Setting}

Doc

Allergy

DOC.ONTOLOGY

2

Allergy Referral note

null

ACTIVE

2.69

95755-5

Initial evaluation note

Find

Pt

{Setting}

Doc

Allergy

DOC.ONTOLOGY

2

Allergy Initial evaluation note

Allergy Initial eval note

null

ACTIVE

2.69

95756-3

Procedure note

Find

Pt

{Setting}

Doc

Allergy

DOC.ONTOLOGY

2

Allergy procedure note

Allergy Procedure note

null

ACTIVE

2.69

95757-1

Progress note

Find

Pt

{Setting}

Doc

Allergy

DOC.ONTOLOGY

2

Allergy Progress note

Allergy Prog note

null

ACTIVE

2.69

2.73

95758-9

Flowsheet

Find

Pt

{Setting}

Doc

Allergy

DOC.ONTOLOGY

2

Allergy Flowsheet

null

ACTIVE

2.69

95759-7

Plan of care note

Find

Pt

{Setting}

Doc

Allergy

DOC.ONTOLOGY

2

Allergy Plan of care note

null

ACTIVE

2.69

9576-0

Rubella virus Ab

ACnc

Pt

CSF

Qn

IA

MICRO

1

Rubella virus Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

RUBV Ab CSF IA-aCnc

null

ACTIVE

1.0i

2.69

95760-5

Education note

Find

Pt

{Setting}

Doc

Allergy

DOC.ONTOLOGY

2

Allergy Education note

Allergy Educ note

null

ACTIVE

2.69

95761-3

Consultation note

Find

Pt

{Setting}

Doc

Allergy

DOC.ONTOLOGY

2

Allergy Consult note

null

ACTIVE

2.69

95762-1

Diagnostic study note

Find

Pt

{Setting}

Doc

Allergy

DOC.ONTOLOGY

2

Allergy Diagnostic study note

Allergy Diag study note

null

ACTIVE

2.69

95763-9

Evaluation note

Find

Pt

{Setting}

Doc

Allergy

DOC.ONTOLOGY

2

Allergy Evaluation note

Allergy Eval note

null

ACTIVE

2.69

95764-7

Candida auris DNA

PrThr

Pt

Urine

Ord

Non-probe.amp.tar

MICRO

1

Candida auris DNA [Presence] in Urine by NAA with non-probe detection

C auris DNA Ur Ql NAA+non-probe

null

ACTIVE

2.69

95765-4

Candida auris DNA

PrThr

Pt

XXX

Ord

Non-probe.amp.tar

MICRO

1

Candida auris DNA [Presence] in Specimen by NAA with non-probe detection

C auris DNA Spec Ql NAA+non-probe

null

ACTIVE

2.69

95766-2

Candida auris DNA

PrThr

Pt

Bld

Ord

Non-probe.amp.tar

MICRO

1

Candida auris DNA [Presence] in Blood by NAA with non-probe detection

C auris DNA Bld Ql NAA+non-probe

null

ACTIVE

2.69

95767-0

Cefiderocol

Susc

Pt

Isolate

OrdQn

Agar diffusion

ABXBACT

1

Cefiderocol [Susceptibility] by Disk diffusion (KB)

Cefiderocol Islt KB

null

ACTIVE

2.69

95768-8

Parathyrin.1-84

SCnc

Pt

Ser/Plas

Qn

IA

CHEM

1

Parathyrin.1-84 [Moles/volume] in Serum or Plasma by Immunoassay

Parathyrin.1-84 SerPl IA-sCnc

null

ACTIVE

2.69

2.71

95769-6

BMPR1A gene deletion+duplication & full mutation analysis

Find

Pt

Bld/Tiss

Doc

Molgen

MOLPATH

1

BMPR1A gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method

BMPR1A Del+Dup + Full Mut Anl Bld/T

null

ACTIVE

2.69

95770-4

GALT gene targeted mutation analysis

Find

Pt

Bld/Tiss

Doc

Molgen

MOLPATH

1

GALT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method

GALT gene Mut Anl Bld/T

null

ACTIVE

2.69

95771-2

GATA2 gene full mutation analysis

Find

Pt

Bld/Tiss

Doc

Sequencing

MOLPATH

1

GATA2 gene full mutation analysis in Blood or Tissue by Sequencing

GATA2 gene Full Mut Anl Bld/T Seq

null

ACTIVE

2.69

95772-0

IDH1 gene & IDH2 gene targeted mutation analysis

Find

Pt

Bld/Tiss

Doc

Molgen

MOLPATH

1

IDH1 and IDH2 genes targeted mutation analysis in Blood or Tissue by Molecular genetics method

IDH1 + IDH2 Mut Anl Bld/T

null

ACTIVE

2.69

95773-8

ACADM gene full mutation analysis

Find

Pt

Bld/Tiss

Doc

Sequencing

MOLPATH

1

ACADM gene full mutation analysis in Blood or Tissue by Sequencing

ACADM gene Full Mut Anl Bld/T Seq

null

ACTIVE

2.69

95774-6

MSH6 gene deletion+duplication & full mutation analysis

Find

Pt

Bld/Tiss

Doc

Molgen

MOLPATH

1

MSH6 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method

MSH6 gene Del+Dup + Full Mut Anl Bld/T

null

ACTIVE

2.69

95775-3

HGSNAT gene full mutation analysis

Find

Pt

Bld/Tiss

Doc

Sequencing

MOLPATH

1

HGSNAT gene full mutation analysis in Blood or Tissue by Sequencing

HGSNAT Full Mut Anl Bld/T Seq

null

ACTIVE

2.69

95776-1

GNS gene full mutation analysis

Find

Pt

Bld/Tiss

Doc

Sequencing

MOLPATH

1

GNS gene full mutation analysis in Blood or Tissue by Sequencing

GNS Full Mut Anl Bld/T Seq

null

ACTIVE

2.69

95777-9

ACADS gene full mutation analysis

Find

Pt

Bld/Tiss

Doc

Sequencing

MOLPATH

1

ACADS gene full mutation analysis in Blood or Tissue by Sequencing

ACADS gene Full Mut Anl Bld/T Seq

null

ACTIVE

2.69

9577-8

Saint Louis encephalitis virus Ab

Titr

Pt

CSF

Qn

IF

MICRO

1

Saint Louis encephalitis virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence

SLEV Ab Titr CSF IF

null

ACTIVE

1.0i

2.7

95778-7

TERT gene promotor region targeted mutation analysis

Find

Pt

Tiss

Doc

Molgen

MOLPATH

1

TERT gene promotor region targeted mutation analysis in Tissue by Molecular genetics method

TERT promotor region Mut Anl Tiss

null

ACTIVE

2.69

95779-5

TFE3 gene rearrangements

Find

Pt

Tiss

Doc

FISH

MOLPATH

1

TFE3 gene rearrangements in Tissue by FISH

TFE3 rearrange Tiss FISH

null

ACTIVE

2.69

95780-3

TFEB gene rearrangements

Find

Pt

Tiss

Doc

FISH

MOLPATH

1

TFEB gene rearrangements in Tissue by FISH

TFEB rearrange Tiss FISH

null

ACTIVE

2.69

95781-1

ATP7B gene full mutation analysis

Find

Pt

Bld/Tiss

Doc

Sequencing

MOLPATH

1

ATP7B gene full mutation analysis in Blood or Tissue by Sequencing

ATP7B gene Full Mut Anl Bld/T Seq

null

ACTIVE

2.69

95782-9

ABCD1 gene full mutation analysis

Find

Pt

Bld/Tiss

Doc

Sequencing

MOLPATH

1

ABCD1 gene full mutation analysis in Blood or Tissue by Sequencing

ABCD1 gene Full Mut Anl Bld/T Seq

null

ACTIVE

2.69

95783-7

ETV6 gene rearrangements

Find

Pt

Bld/Bone mar

Doc

FISH

MOLPATH

1

ETV6 gene rearrangements in Blood or Marrow by FISH

ETV6 rearrange Bld/Mar FISH

null

ACTIVE

2.69

95784-5

FGFR2 gene rearrangements

Find

Pt

Tiss

Doc

FISH

MOLPATH

1

FGFR2 gene rearrangements in Tissue by FISH

FGFR2 rearrange Tiss FISH

null

ACTIVE

2.69

95785-2

FOXL2 gene targeted mutation analysis

Find

Pt

Tiss

Doc

Molgen

MOLPATH

1

FOXL2 gene targeted mutation analysis in Tissue by Molecular genetics method

FOXL2 Mut Anl Tiss

null

ACTIVE

2.69

9578-6

Saint Louis encephalitis virus Ab

Titr

Pt

Ser

Qn

IF

MICRO

1

Saint Louis encephalitis virus Ab [Titer] in Serum by Immunofluorescence

SLEV Ab Titr Ser IF

null

ACTIVE

1.0i

2.73

95786-0

Gene XXX mutation analysis limited to known familial mutations

Find

Pt

Bld/Tiss

Doc

Molgen

MOLPATH

1

Gene XXX mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method

Gene XXX Fam Mut Anl Bld/T

null

ACTIVE

2.69

95787-8

Adrenal cortical carcinoma probability

Likelihood

Pt

^Patient

Qn

Based on clinical data

CLIN.RISK

2

Adrenal cortical carcinoma probability [Likelihood] based on clinical data

ACC Prob from clin data

null

ACTIVE

2.69

95788-6

Adrenal malignancy other than adrenal cortical carcinoma probability

Likelihood

Pt

^Patient

Qn

Based on clinical data

CLIN.RISK

2

Adrenal malignancy other than ACC probability [Likelihood] based on clinical data

Other adrenal malig Prob from clin data

null

ACTIVE

2.69

95789-4

Benign mass probability

Likelihood

Pt

^Patient

Qn

Based on clinical data

CLIN.RISK

2

Benign mass probability [Likelihood] based on clinical data

Benign mass Prob from clin data

null

ACTIVE

2.69

95790-2

Adrenal cortical carcinoma probability

Likelihood

Pt

^Patient

Qn

Based on clinical+lab data

CLIN.RISK

2

Adrenal cortical carcinoma probability [Likelihood] based on clinical and lab data

ACC Prob from clin+lab data

null

ACTIVE

2.69

95791-0

Adrenal malignancy other than adrenal cortical carcinoma probability

Likelihood

Pt

^Patient

Qn

Based on clinical+lab data

CLIN.RISK

2

Adrenal malignancy other than ACC probability [Likelihood] based on clinical and lab data

Other adrenal malig Prob clin+lab data

null

ACTIVE

2.69

95792-8

Benign mass probability

Likelihood

Pt

^Patient

Qn

Based on clinical+lab data

CLIN.RISK

2

Benign mass probability [Likelihood] based on clinical and lab data

Benign mass Prob from clin+lab data

null

ACTIVE

2.69

95793-6

Immunization priority tier

Type

Pt

^Patient

Nom

null

PUBLICHEALTH

2

Immunization priority tier

null

ACTIVE

2.69

9579-4

Tetrahydrocorticosterone

MRat

24H

Urine

Qn

null

CHEM

1

Tetrahydrocorticosterone [Mass/time] in 24 hour Urine

THB 24h Ur-mRate

null

ACTIVE

1.0i

2.42

95794-4

Adrenal insufficiency emergency action plan

Find

Pt

{Setting}

Doc

{Role}

DOC.ONTOLOGY

2

Adrenal insufficiency emergency action plan

Adrenal insufficiency action plan

null

ACTIVE

2.69

95795-1

HBG1 gene & HBG2 gene full mutation analysis

Find

Pt

Bld/Tiss

Doc

Sequencing

MOLPATH

1

HBG1 and HBG2 genes full mutation analysis in Blood or Tissue by Sequencing

HBG1 + HBG2 Full Mut Anl Bld/T Seq

null

ACTIVE

2.69

2.73

95796-9

Opioids panel

-

Pt

Urine

-

Screen

PANEL.DRUG/TOX

1

Opioids panel - Urine by Screen method

Opioids Pnl Ur Scn

null

ACTIVE

2.69

95797-7

Norfentanyl

PrThr

Pt

Urine

Ord

Screen

DRUG/TOX

1

Norfentanyl [Presence] in Urine by Screen method

Norfentanyl Ur Ql Scn

null

ACTIVE

2.69

95798-5

Normeperidine

PrThr

Pt

Urine

Ord

Screen

DRUG/TOX

1

Normeperidine [Presence] in Urine by Screen method

Normeperidine Ur Ql Scn

null

ACTIVE

2.69

95799-3

O-nortramadol

PrThr

Pt

Urine

Ord

Screen

DRUG/TOX

1

O-nortramadol [Presence] in Urine by Screen method

O-nortramadol Ur Ql Scn

null

ACTIVE

2.69

95800-9

Immunoglobulin light chains.free panel

-

Urine

-

null

PANEL.CHEM

1

Immunoglobulin light chains.free panel - Urine

Immunoglobulin LC free Pnl Ur

null

ACTIVE

2.69

95801-7

Immunoglobulin light chains.free & immunofixation panel

-

Urine

-

null

PANEL.CHEM

1

Immunoglobulin light chains.free and IFE panel - Urine

Immunoglobulin LC free + IFE Pnl Ur

null

ACTIVE

2.69

9580-2

Thyroxine Ab

ACnc

Pt

Ser

Qn

null

SERO

1

Thyroxine (T4) Ab [Units/volume] in Serum

T4 Ab Ser-aCnc

null

ACTIVE

1.0i

2.73

95802-5

Progress note

Find

Pt

{Setting}

Doc

Breastfeeding

DOC.ONTOLOGY

2

Breastfeeding Progress note

Breastfeeding Prog note

null

ACTIVE

2.69

2.73

95803-3

Note

Find

Pt

{Setting}

Doc

Breastfeeding

DOC.ONTOLOGY

2

Breastfeeding Note

null

ACTIVE

2.69

95804-1

Note

Find

Pt

Telehealth

Doc

Breastfeeding

DOC.ONTOLOGY

2

Breastfeeding Telehealth Note

null

ACTIVE

2.69

95805-8

Evaluation note

Find

Pt

{Setting}

Doc

Breastfeeding

DOC.ONTOLOGY

2

Breastfeeding Evaluation note

Breastfeeding Eval note

null

ACTIVE

2.69

95806-6

Consultation note

Find

Pt

{Setting}

Doc

Breastfeeding

DOC.ONTOLOGY

2

Breastfeeding Consult note

null

ACTIVE

2.69

95807-4

Chylomicrons

PrThr

Pt

Urine

Ord

null

CHEM

1

Chylomicrons [Presence] in Urine

Chylo Ur Ql

null

ACTIVE

2.69

95808-2

Cholesterol & triglyceride & chylomicrons panel

-

Pt

Urine

-

null

PANEL.CHEM

1

Cholesterol and triglyceride and chylomicrons panel - Urine

Cholest+triglyceride+chylomicrons Pnl Ur

null

ACTIVE

2.69

95809-0

Carbapenem resistance genes

PrThr

Pt

Isolate/Specimen

Ord

Molgen

ABXBACT

1

Carbapenem resistance genes [Presence] by Molecular method

CPR genes Islt/Spm Ql

null

ACTIVE

2.69

9581-0

Western equine encephalitis virus Ab

Titr

Pt

Ser

Qn

IF

MICRO

1

Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence

WEEV Ab Titr Ser IF

null

ACTIVE

1.0i

2.73

95810-8

IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Functional abilities and goals - discharge

-

RptPeriod

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Functional abilities and goals - discharge [CMS Assessment]

null

ACTIVE

2.69

2.7

95811-6

IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Functional abilities and goals - admission

-

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Functional abilities and goals - admission [CMS Assessment]

null

ACTIVE

2.69

2.7

95812-4

Did the patient have difficulty focusing attention, for example, being easily distractible or having difficulty keeping track of what was being said

Find

RptPeriod

^Patient

Ord

CAM.CMS

SURVEY.CMS

4

Did the patient have difficulty focusing attention, for example, being easily distractible or having difficulty keeping track of what was being said during assessment period [CAM.CMS]

null

Copyright © 2003 Sharon K. Inouye, M.D., MPH. Adapted from: Inouye SK, vanDyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: The Confusion Assessment Method. A new method for detection of delirium. Ann Intern Med. 1990; 113: 941-948. Confusion Assessment Method: Training Manual and Coding Guide. Used with permission.

ACTIVE

2.69

95813-2

Is there evidence of an acute change in mental status from the patient's baseline

Find

RptPeriod

^Patient

Ord

CAM.CMS

SURVEY.CMS

4

Is there evidence of an acute change in mental status from the patient's baseline during assessment period [CAM.CMS]

null

Copyright © 2003 Sharon K. Inouye, M.D., MPH. Adapted from: Inouye SK, vanDyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: The Confusion Assessment Method. A new method for detection of delirium. Ann Intern Med. 1990; 113: 941-948. Confusion Assessment Method: Training Manual and Coding Guide. Used with permission.

ACTIVE

2.69